KemPharm Inc

NASDAQ:KMPH   3:59:57 PM EDT
4.51
-0.18 (-3.84%)
Earnings Announcements

KemPharm Reports Q4 Loss Per Share Of $0.08

Published: 03/30/2022 20:21 GMT
KemPharm Inc (KMPH) - Kempharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates.
Q4 Loss per Share $0.08.
Q4 Revenue $2.6 Million Versus $2.4 Million.
Revenue is expected to be $1.75 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $3.25 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.